1.
Chakraborty P, Chakraborty K. Anti-fibrotic agents could be the game-changer for post-COVID-19 pulmonary fibrosis treatment. European Journal of Biological Research [Internet]. 1Jan.2022 [cited 28Mar.2024];12(1):1-0. Available from: https://journals.tmkarpinski.com/index.php/ejbr/article/view/519